PHARMA MAR, S.A. «...1617181920...» Page 18 out of 22 05/08/2020 18:27 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The company reports the transactions performed in the context of the Share Buy-back Program between 29 July and 4 August 2020. Register number: 4008 30/07/2020 13:00 PHARMA MAR, S.A. Half-yearly financial reports and audit reports/limited audit review La sociedad remite información financiera del primer semestre de 2020 Register number: 3782 29/07/2020 18:10 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The company reports the transactions performed in the context of the Share Buy-back Program between 22 July and 28 July 2020. Register number: 3747 23/07/2020 09:50 PHARMA MAR, S.A. Total number of voting rights and capital Total de derechos de voto y del capital tras la reducción de capital y agrupación y canje de acciones (contra-split) Register number: 3561 22/07/2020 17:51 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The company reports the transactions performed in the context of the Share Buy-back Program between 15 July and 21 July 2020. Register number: 3544 22/07/2020 08:29 PHARMA MAR, S.A. Other relevant information The Company informs of the admission to trading as of today of the new shares in the Stock Exchanges after the execution of the agreement of capital reduction and consolidation and exchange of shares (contra-split) Register number: 3518 Related to communication no. 3401 dated 14/07/2020 (17:40) 15/07/2020 17:38 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The company reports the transactions performed in the context of the Share Buy-back Program between 8 July and 14 July 2020. Register number: 3411 14/07/2020 17:40 PHARMA MAR, S.A. Other relevant information Registration within the Madrid Mercantile Registry of the resolution to reduce capital and consolidation and exchange of shares (contra-split) Register number: 3401 08/07/2020 17:42 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The company reports the transactions performed in the context of the Share Buy-back Program between 1 July and 7 July 2020. Register number: 3313 02/07/2020 09:30 PHARMA MAR, S.A. On business and financial situation The Company announces that its partner in South Korea, Boryung Pharmaceutical, has presented the results of in vitro studies of plitidepsin (Aplidin®) in SARS-CoV-2. Register number: 3138 Page 18 out of 22 «...1617181920...»
